Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation Plans and Awards (Tables)

v2.4.1.9
Stock-based Compensation Plans and Awards (Tables)
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of shares available for grant and activity
Shares available for grant as of December 31, 2014 and the activity during the twelve months ended December 31, 2014 are as follows:
 
Shares Available for Grant
 
Equity Awards
 
ESPP
 
Total
Balance as of December 31, 2013
9,048,200

 

 
9,048,200

Additional shares authorized
7,815,837

 
4,000,000

 
11,815,837

Options granted
(349,500
)
 

 
(349,500
)
Restricted stock granted
(4,909,360
)
 

 
(4,909,360
)
ESPP shares issued

 
(142,265
)
 
(142,265
)
Options forfeited
1,639,935

 

 
1,639,935

Restricted stock forfeited
1,081,348

 

 
1,081,348

Balance as of December 31, 2014
14,326,460

 
3,857,735

 
18,184,195

Schedule of assumptions used for determining the per-share fair value of shares granted under the ESPP
The per-share fair value of shares to be granted under the ESPP is determined on the first day of the offering period using the Black-Scholes option pricing model using the following assumptions:
 
        
 
Twelve months ended 
 December 31,
 
2014
Expected life (in years)
0.5

Risk-free interest rate
0.06
%
Expected volatility
42
%
Expected dividend yield
0
%
Schedule of stock option activity
Stock option activity during the twelve months ended December 31, 2014 was as follows:
 
Options Outstanding
 
Outstanding
Stock Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term (in years)
 
Aggregate Intrinsic Value (1)
 
(in thousands, except share and per share data)
Balance as of December 31, 2013
22,708,200

 
$
4.85

 
5.76
 
$
493,866

Granted
349,500

 
35.61

 
 
 
 
Exercised
(10,437,509
)
 
1.62

 
 
 
 
Forfeited
(1,639,935
)
 
11.49

 
 
 
 
Balance as of December 31, 2014
10,980,256

 
7.91

 
1.08
 
120,033

Exercisable as of December 31, 2014
7,958,775

 
4.39

 
0.40
 
108,296

Expected to vest as of December 31, 2014 (2)
2,719,853

 
$
17.05

 
2.82
 
$
10,822

 
 
 
 
 
 
 
 
(1)Amounts represent the difference between the exercise price and the fair value of common stock at each period end for all in the money options outstanding based on the fair value per share of common stock of $26.60 and $17.83 as of December 31, 2013 and 2014.
 
 
(2)Options expected to vest reflect an estimated forfeiture rate.
 
 

Schedule of assumptions used for estimating the per-share fair value of stock options
The per-share fair value of stock options granted during the twelve months ended January 31, 2013, the eleven months ended December 31, 2013 and the twelve months ended December 31, 2014 was determined on the grant date using the Black-Scholes option pricing model with the following assumptions:
 
Twelve months ended 
 January 31,
 
Eleven months ended 
 December 31,
 
Twelve months ended 
 December 31,
 
2013
 
2013
 
2014
Expected life (in years)
6.02 - 6.67

 
5.99 - 6.32

 
6.08

Risk-free interest rate
0.99% - 1.52%

 
1.00% - 2.04%

 
1.71% - 1.93%

Expected volatility
56% - 57%

 
58% - 59%

 
58% - 59%

Expected dividend yield
0
%
 
0
%
 
0
%
Schedule of activities for RSUs
The following table summarizes the activities for our RSUs for the twelve months ended December 31, 2014:

 
Number of RSUs
 
Weighted-Average Grant Date Fair Value
Unvested as of December 31, 2013
10,365,512

 
$
14.31

Granted
4,909,360

 
32.29

Vested
(3,169,456
)
 
13.85

Forfeited
(1,081,348
)
 
19.06

Unvested as of December 31, 2014
11,024,068

 
21.99

Expected to vest as of December 31, 2014 (1)
9,914,453

 
$
21.88

(1) RSUs expected to vest reflect an estimated forfeiture rate.
 
 
 
Schedule of stock-based compensation expenses related to all employee and non-employee stock-based awards
Stock-based compensation expense related to all employee and non-employee stock-based awards was as follows:
 
 
Twelve months ended 
 January 31,
 
Eleven months ended 
 December 31,
 
Twelve months ended 
 December 31,
 
2013
 
2013
 
2014
 
(in thousands)
Stock-based compensation expense
 

 
 

 
 

Cost of revenueOther
$
1,214

 
$
1,946

 
$
4,414

Product development
4,530

 
8,802

 
17,546

Sales and marketing
12,294

 
20,222

 
42,165

General and administrative
7,462

 
9,071

 
22,930

Total stock-based compensation expense
$
25,500

 
$
40,041

 
$
87,055